InspireMD Inc.

InspireMD Inc.
Stock Exchange NYSE
EPS
$16.73
Market Cap
$4.93 M
Shares Outstanding
1.4 M
Public Float
37.08 M

Profile

Address
4 Menorat Hamaor Street
Tel Aviv TA 67448
Israel
Employees -
Website http://www.inspiremd.com
Updated 07/08/2019
InspireMD, Inc. is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.

Financials

View All

James J. Barry
President, Chief Executive Officer & Director
Paul S. Stuka
Chairman